Whole-genome sequencing informs treatment: Personalized medicine takes another step forward

Clinical Chemistry

Volumn 57, Issue 12, 2011, Pages 1638-1640

  Morrison, Karen E ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; CLOPIDOGREL; CYTOCHROME P450 2C19; ENTACAPONE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID RECEPTOR ALPHA; SEPIAPTERIN REDUCTASE; TYROSINE 3 MONOOXYGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; DNA POLYMORPHISM; DNA SEQUENCE; DYSTONIA; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; LEVODOPA RESPONSIVE DYSTONIA; LOW DRUG DOSE; PARKINSON DISEASE; PERSONALIZED MEDICINE; PHENOTYPE; PROGNOSIS; SHORT SURVEY; WHOLE GENOME SEQUENCING;

5-HYDROXYTRYPTOPHAN; ALCOHOL OXIDOREDUCTASES; CHROMOSOMES, HUMAN, PAIR 17; DYSTONIC DISORDERS; GENE FUSION; GENOME, HUMAN; HUMANS; INDIVIDUALIZED MEDICINE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, RETINOIC ACID; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC;

EID: 82755167825     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.172684     Document Type: Short Survey

References (5)

1. Cannon CP. Clopidogrel: to test or not to test? That is the question - still. Clin Chem 2011;57:659-61.
2. Corvol J-C, Bonnet C, Charbonnier-Beaupel F, Bonnet A-M, Fievet M-H, Bellanger A, et al. The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial. Ann Neurol 2011;69:111-8.
3. Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jaurequi C, Newsham I, et al. Whole-genome sequencing for optimized patient management. Sci Transl Med 2011;3:87re3.
4. Clot F, Grabli D, Cazeneuve C, Roze E, Castelnau P, Chabrol B, et al. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain 2009;132:1753-63.
5. Welch JS, Westervelt P, Ding L, Larson DE, Klco JM, Kulkarni S, et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 2011;305:1577-84.